Aflac (AFL)

Many investors focus on the dividend yield, but not much on the dividend growth.

Dividend Aristocrats have shown mixed 2025 performance, with some delivering double-digit gains and others lagging, but overall stability remains a hallmark. Dividend growth is robust, with 53 of 69 A...

Buy Aflac for its high-interest rate sensitivity, superior financial strength, and best-in-class capital return strategy amid a steepening yield curve. Aflac's dominant Japan exposure, iconic brand, l...

I am downgrading AFL to a hold due to slowing revenue and earnings growth and a premium valuation versus peers. AFL's Q2 results showed declining revenue and EPS, with investment losses and Japan segm...

Aflac (AFL) has been upgraded to a Zacks Rank #2 (Buy), reflecting growing optimism about the company's earnings prospects. This might drive the stock higher in the near term.

On 8/20/25, Loews, AFLAC, and Marketaxess Holdings will all trade ex-dividend for their respective upcoming dividends. Loews will pay its quarterly dividend of $0.0625 on 9/2/25, AFLAC will pay its qu...

AFL boosts its buyback plan to 130.9M shares as strong sales in Japan and higher U.S. margins fuel shareholder returns.

AFL's Q2 earnings benefit from robust Japan cancer insurance sales and strong persistency rates in the U.S. business, partly offset by rising costs.

Aflac Incorporated (NYSE:AFL ) Q2 2025 Earnings Call August 6, 2025 8:00 AM ET Company Participants Daniel Paul Amos - Chairman & CEO David Young - Corporate Participant Koichiro Yoshizumi - Senior Ma...

While the top- and bottom-line numbers for Aflac (AFL) give a sense of how the business performed in the quarter ended June 2025, it could be worth looking at how some of its key metrics compare to Wa...